Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isoflurane via AnaConDa-S versus intravenous midazolam for paediatric ICU sedation
2020-000578-31Phase 3Completed
- Sponsor
- Sedana Medical
- Start
- Jun 2020
- Modality
- Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in None comparing Isoflurane arm with Midazolam arm (2 arms). Primary endpoint: Percentage of time of adequately maintained sedation within the prescribed COMFORT-B interval without rescue sedation. Started Jun 2020; status: completed.
02
Drugs
isofluranemidazolam
Beyond the preview
Go deeper on 2020-000578-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-000578-31.